Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Financial Planning > Behavioral Finance

BISYS CEO To Step Down For Medical Reasons

By Staff Writer

X
Your article was successfully shared with the contacts you provided.

NU Online News Service, Oct. 9, 2003, 5:30 p.m. EST – The BISYS Group Inc., New York, says Dennis Sheehan, its president and chief executive officer, will be stepping down for medical reasons.

BISYS sells support services to financial services companies and also markets financial services training programs.

Sheehan has an accident-related medical condition that is not life threatening but will prevent him from continuing to serve as chief executive of BISYS, Sheehan says in a statement.

“I am disappointed that I need to step down prematurely,” Sheehan says. “I want to emphasize that my decision is completely unrelated to the recent earnings disappointments and I remain confident in our recently set financial guidance, and in the long-term prospects for the company.”

Sheehan has been president of BISYS since August 2001 and chief executive since October 2002.

Lynn Mangum, the company’s chairman, will keep that title.

BISYS has hired Korn/Ferry International to help it find a successor for Sheehan. Sheehan will continue to serve as president and CEO until BISYS chooses the successor, BISYS says.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.